Clinical usefulness of inside stents in anastomotic biliary strictures after liver transplantation

Author:

Kugiyama Naotaka1,Hashigo Shunpei1,Nagaoka Katsuya1,Watanabe Takehisa1,Ushijima Shinya1,Uramoto Yukiko1,Yoshinari Motohiro1,Morinaga Jun2,Gushima Ryosuke1,Tateyama Masakuni1,Tanaka Motohiko3,Naoe Hideaki1,Sugawara Yasuhiko4,Hibi Taizo4,Tanaka Yasuhito1ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Kumamoto University Hospital Kumamoto Japan

2. Department of Clinical Investigation Kumamoto University Hospital Kumamoto Japan

3. Department of Public Health and Welfare Kumamoto Japan

4. Department of Pediatric Surgery and Transplantation Kumamoto University Hospital Kumamoto Japan

Abstract

AbstractBackgroundEndoscopic biliary stenting is a standard treatment for biliary strictures after liver transplantation. Plastic stents are often replaced before stent dysfunction to prevent the development of cholangitis and jaundice. Therefore, the precise duration of stent patency is unclear.MethodsWe compared retrospectively the stent patency period and stent dysfunction rate between inside stents (IS) and conventional plastic stents (PS) in 48 patients with post‐transplant strictures, distinguishing endoscopic biliary stenting with and without stent dysfunction at stent replacement.ResultsIn observations focused on the first treatment, the median patency periods were 369 days for IS (n = 18) and 154 days for PS (n = 30; p = 0.01), significantly longer for IS. The 1‐year cholangitis incidence rate was lower for IS (20% vs. 43%, p = 0.04). Additionally, no stent dislocation was observed for IS, but this occurred for 33.3% of PS (p = 0.004). Comparing all endoscopic biliary stenting, including second and subsequent procedures, IS again had a longer patency period than PS (356 days, n = 89, vs. 196 days, n = 127, p = 0.009).ConclusionsIS had a significantly longer patency period than PS, suggesting that IS replacement could be reduced to once per year for patients who prefer less frequent stent replacement.

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Organic Chemistry,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3